EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway

Aiqiu Wei, Ziyi Zhong, Yiming Zhang, Jincheng He iD, Haihe Pang, Xinhua Xia iD, Xiaoqing Zhang

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s556912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Aiqiu Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China. Hauptthemen laut MEDLINE: Liposomes, Liver Neoplasms, Carcinoma, Hepatocellular, Cantharidin. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesLiver NeoplasmsCarcinoma, HepatocellularCantharidinAptamers, NucleotideAnimalsTOR Serine-Threonine KinasesHumansMiceHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor ACell Line, TumorAntineoplastic AgentsDrug SynergismSignal TransductionMice, Inbred BALB CMice, NudeNanoparticlesMaleXenograft Model Antitumor Assays

Stichwörter der Autor:innen

aptamercantharidindrug co-deliveryhepatocellular carcinomastaurosporine

Substanzen

LiposomesTOR Serine-Threonine KinasesHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor ACantharidinAptamers, NucleotideAntineoplastic AgentsMTOR protein, humanHIF1A protein, human

Autor:innen und Institutionen

  • School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Hunan Kelun Pharmaceutical Co., Ltd, Yueyang, 414024, People's Republic of China.

ORCID-Profile: Jincheng He, Xinhua Xia

Zitieren

APA

Wei, A., Zhong, Z., Zhang, Y., He, J., Pang, H., Xia, X., & Zhang, X. (2026). Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s556912

Vancouver

Wei A, Zhong Z, Zhang Y, He J, Pang H, Xia X, et al. Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s556912

BibTeX
@article{Wei2026,
  author = {Wei, Aiqiu and Zhong, Ziyi and Zhang, Yiming and He, Jincheng and Pang, Haihe and Xia, Xinhua and Zhang, Xiaoqing},
  title = {Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s556912}
}
Kostenlos starten →